0

Journal Articles

in Cardiovascular Disease Prevention
 81-100 of 264 Articles
JAMA | 
Editorial |  December 28, 2011
ADHD Medications and Cardiovascular Risk:  Some Heartening News
Philip Shaw, MD, PhD
JAMA. 2011;306(24):2723-2724. doi:10.1001/jama.2011.1866.
JAMA | 
Editorial |  November 23, 2011
Urinary Sodium and Cardiovascular Disease Risk:  Informing Guidelines for Sodium Consumption
Paul K. Whelton, MB, MD, MSc
JAMA. 2011;306(20):2262-2264. doi:10.1001/jama.2011.1746.
JAMA | 
Commentary |  November 16, 2011
Prevention of Cardiovascular Disease and Stroke:  Meeting the Challenge
JAMA. 2011;306(19):2147-2148. doi:10.1001/jama.2011.1668.
JAMA | 
Original Contribution |  November 16, 2011 FREE
Number of Coronary Heart Disease Risk Factors and Mortality in Patients With First Myocardial Infarction
John G. Canto, MD, MSPH; Catarina I. Kiefe, MD, PhD; William J. Rogers, MD; et al.
JAMA. 2011;306(19):2120-2127. doi:10.1001/jama.2011.1654.
JAMA Internal Medicine | 
Review Article |  November 14, 2011 FREE
The Effect of Lifestyle Modification and Cardiovascular Risk Factor Reduction on Erectile Dysfunction:  A Systematic Review and Meta-analysis
Bhanu P. Gupta, MD; M. Hassan Murad, MD; Marisa M. Clifton, MD; et al.
Arch Intern Med. 2011;171(20):1797-1803. doi:10.1001/archinternmed.2011.440.
INCLUDES: , Supplemental Content
JAMA Dermatology | 
Correspondence |  November 01, 2011
Cutaneous Infarction Under IL-12/23 p40 Inhibition: A Cautionary Note
Dan Lipsker, MD, PhD; Virginie Lutz, MD
Arch Dermatol. 2011;147(11):1344-1345. doi:10.1001/archdermatol.2011.318.
JAMA Internal Medicine | 
Invited Commentary |  October 24, 2011
Cardiovascular Risk Stratification, Hemoglobin A1c, and the Tempo of Translation:  Comment on “Cardiovascular Risk Prediction in Diabetic Men and Women Using Hemoglobin A1c vs Diabetes as a High-Risk Equivalent”
Mark J. Pletcher, MD, MPH
Arch Intern Med. 2011;171(19):1718-1720. doi:10.1001/archinternmed.2011.352.
JAMA Internal Medicine | 
Original Investigation |  October 24, 2011 FREE
Cardiovascular Risk Prediction in Diabetic Men and Women Using Hemoglobin A1c vs Diabetes as a High-Risk Equivalent
Nina P. Paynter, PhD; Norman A. Mazer, MD, PhD; Aruna D. Pradhan, MD; et al.
Arch Intern Med. 2011;171(19):1712-1718. doi:10.1001/archinternmed.2011.351.
INCLUDES: , Supplemental Content
JAMA Internal Medicine | 
Editor's Correspondence |  September 12, 2011
Hypoglycemia Associated With Impaired Renal Function
Adam M. Ali, BA(Cantab)
Arch Intern Med. 2011;171(16):1512. doi:10.1001/archinternmed.2011.378.
JAMA Internal Medicine | 
Review Article |  September 12, 2011 FREE
Impact of Pharmacist Care in the Management of Cardiovascular Disease Risk Factors:  A Systematic Review and Meta-analysis of Randomized Trials
Valérie Santschi, PharmD, PhD; Arnaud Chiolero, MD, MSc; Bernard Burnand, MD, MPH; et al.
Arch Intern Med. 2011;171(16):1441-1453. doi:10.1001/archinternmed.2011.399.
JAMA Internal Medicine | 
Correction |  July 25, 2011
Last-minute Change in June 27 Table of Contents
Arch Intern Med. 2011;171(14):1224. doi:10.1001/archinternmed.2011.366.
JAMA | 
Commentary |  June 22, 2011
Vitamin D and Prevention of Cardiovascular Disease and Diabetes:  Why the Evidence Falls Short
Sue A. Shapses, PhD; JoAnn E. Manson, MD, DrPH
JAMA. 2011;305(24):2565-2566. doi:10.1001/jama.2011.881.
JAMA Internal Medicine | 
Original Investigation |  May 23, 2011 FREE
Effects of Benefits and Harms on Older Persons' Willingness to Take Medication for Primary Cardiovascular Prevention
Terri R. Fried, MD; Mary E. Tinetti, MD; Virginia Towle, MPhil; et al.
Arch Intern Med. 2011;171(10):923-928. doi:10.1001/archinternmed.2011.32.
JAMA | 
The World in Medicine |  April 20, 2011
Genes for Heart Disease Risk
M. J. Friedrich
JAMA. 2011;305(15):1527. doi:10.1001/jama.2011.476.
JAMA Internal Medicine | 
Invited Commentary |  March 14, 2011
Diabetes and Cardiovascular Risk Equivalency: Do Age at Diagnosis and Disease Duration Affect Risk Stratification?:  Comment on “Impact of Diabetes on Cardiovascular Disease Risk and All-Cause Mortality in Older Men”
Iskandar Idris, DM, FRCP
Arch Intern Med. 2011;171(5):410-411. doi:10.1001/archinternmed.2010.524.
JAMA Internal Medicine | 
Articles |  February 28, 2011
Error in Wording in: Persistence of Cardiovascular Risk After Rofecoxib Discontinuation
Arch Intern Med. 2011;171(4):305. doi:10.1001/archinternmed.2010.546.
JAMA Internal Medicine | 
Original Investigation |  February 14, 2011 FREE
Cost-Utility of Aspirin and Proton Pump Inhibitors for Primary Prevention
Stephanie R. Earnshaw, PhD; James Scheiman, MD; A. Mark Fendrick, MD; et al.
Arch Intern Med. 2011;171(3):218-225. doi:10.1001/archinternmed.2010.525.
INCLUDES: , Supplemental Content
JAMA | 
Medical News & Perspectives |  January 26, 2011
Studies Hint at Benefits of Imaging as a Screening Tool to Detect Coronary Risk
Mike Mitka
JAMA. 2011;305(4):346-347. doi:10.1001/jama.2010.1962.
JAMA | 
Medical News & Perspectives |  January 12, 2011
CETP Inhibition Shows Promise as Way to Reduce Cardiovascular Disease Risk
Mike Mitka
JAMA. 2011;305(2):136-137. doi:10.1001/jama.2010.1908.
JAMA Internal Medicine | 
Research Letters |  December 13, 2010 FREE
Persistence of Cardiovascular Risk After Rofecoxib Discontinuation
Joseph S. Ross, MD, MHS; David Madigan, PhD; Marvin A. Konstam, MD; et al.
Arch Intern Med. 2010;170(22):2035-2036. doi:10.1001/archinternmed.2010.461.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
RESEARCH LETTER  |  June 17, 2013
ω-3 Fatty Acid Supplements for Secondary Prevention of Cardiovascular Disease: From “No Proof of Effectiveness” to “Proof of No Effectiveness”
Andrea Messori, PharmD; Valeria Fadda, PharmD; Dario Maratea, PharmD; et al.
JAMA
Original Contribution  |  June 12, 2013
Clinical Ascertainment of Health Outcomes Among Adults Treated for Childhood Cancer
Melissa M. Hudson, MD; Kirsten K. Ness, PT, PhD; James G. Gurney, PhD; et al.
JAMA Internal Medicine
Editor's Correspondence  |  June 10, 2013
Noncommunicable Diseases in Developing Countries: Focus on Research Capacity Building
Ayodele Odutayo, BHSc; Naheed Hirji, BASc
JAMA
Original Contribution  |  May 15, 2013
Association of Single- vs Dual-Chamber ICDs With Mortality, Readmissions, and Complications Among Patients Receiving an ICD for Primary Prevention
Pamela N. Peterson, MD, MSPH; Paul D. Varosy, MD; Paul A. Heidenreich, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems